Cullinan Oncology Inc (NASDAQ: CGEM) closed the day trading at $15.32 down -3.83% from the previous closing price of $15.93. In other words, the price has decreased by -$0.61 from its previous closing price. On the day, 321121 shares were traded. CGEM stock price reached its highest trading level at $16.00 during the session, while it also had its lowest trading level at $15.26.
Ratios:
For a better understanding of CGEM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.07 and its Current Ratio is at 17.07. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on February 15, 2024, initiated with a Outperform rating and assigned the stock a target price of $30.
On November 21, 2022, BTIG Research started tracking the stock assigning a Buy rating and target price of $20.BTIG Research initiated its Buy rating on November 21, 2022, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 01 ’24 when Savill Corrine sold 40,000 shares for $16.18 per share. The transaction valued at 647,200 led to the insider holds 165,990 shares of the business.
Savill Corrine sold 40,000 shares of CGEM for $563,600 on Jan 29 ’24. The Chief Business Officer now owns 165,990 shares after completing the transaction at $14.09 per share. On Jan 23 ’24, another insider, Savill Corrine, who serves as the Chief Business Officer of the company, sold 21,316 shares for $12.46 each. As a result, the insider received 265,597 and left with 165,990 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CGEM now has a Market Capitalization of 659.77M and an Enterprise Value of 196.29M.
Stock Price History:
Over the past 52 weeks, CGEM has reached a high of $19.68, while it has fallen to a 52-week low of $7.64. The 50-Day Moving Average of the stock is 15.57, while the 200-Day Moving Average is calculated to be 11.39.
Shares Statistics:
Over the past 3-months, CGEM traded about 406.64K shares per day on average, while over the past 10 days, CGEM traded about 559.13k shares per day. A total of 42.90M shares are outstanding, with a floating share count of 26.45M. Insiders hold about 38.57% of the company’s shares, while institutions hold 64.04% stake in the company. Shares short for CGEM as of Feb 29, 2024 were 694.1k with a Short Ratio of 1.71, compared to 1.47M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.62% and a Short% of Float of 2.01%.
Earnings Estimates
Current recommendations for the stock of the company come from 7 analysts. On average, analysts expect EPS of -$0.95 for the current quarter, with a high estimate of -$0.85 and a low estimate of -$1.12, while EPS last year was -$1.42. The consensus estimate for the next quarter is -$0.94, with high estimates of -$0.78 and low estimates of -$1.12.
Analysts are recommending an EPS of between -$3.21 and -$4.45 for the fiscal current year, implying an average EPS of -$3.74. EPS for the following year is -$3.34, with 6 analysts recommending between -$2.71 and -$3.95.
